fbpx
logo
searchGET STARTEDlinecall855-522-5297
What are you looking for?

After recalls and warnings due to safety concerns and injuries, FDA tells doctors and patients – do not use Biozorb. Patients should speak with their healthcare providers. Then contract KBA.

KBA is Litigating BioZORB Cases

KBA has an attorney licensed in Massachusetts where this litigation resides. Our partner heading the litigation has vast medical device experience including trying medical device cases. The legs team working on Biozorb is skilled at caring for clients and getting cases worked-up quickly. Thus, KBA is well-positioned to help people BioZORB injured.

Michael Appel is an attorney in the state where the company is located, Massachusetts. He has litigated medical device cases, complex medical malpractice cases, and more for decades. A true trial lawyer, Michael has led complex litigations and mentors KBA’s attorneys. Michael tried device cases and will be with us if and when we have a Biozorb trial.

Partner Robert Price has litigated many medical device cases. He recently tried one in NJ. He hails from a preeminent firm and has taken the reigns of the medical device team here at KBA. Our firm is passionate about fighting this matter. Robert investigate each Biozorb case and is helping lead the litigation.

BIOZORB Medical Device Recall: Impact and Risks

The U.S. Food and Drug Administration (FDA) has classified the recall of Hologic’s BioZorb Marker as a Class I recall, the most serious type, indicating a high risk of serious injury or death. This recall, initiated on March 13, 2024, affects 53,492 devices distributed between April 29, 2019, and April 1, 2024.

In October, FDA warned the community – do not use BioZorb. The case against this product couldn’t be any more clear.

Reported Issues and Complications BioZorb Allegedly Causes

The BioZorb recall arose from numerous reports of complications and adverse events associated with the BioZorb Marker, including:

  • Pain
  • Infection
  • Rash
  • Device migration and erosion
  • Seroma (fluid buildup)
  • Discomfort
  • Necessity for additional medical treatment to remove the device

As of now, 71 injuries have been reported, although no deaths have been associated with the device​ (FDA)​​ (FDA)​​ (MPO Magazine)​.

Usage and Distribution

The BioZorb Marker is an implantable radiographic marker used to mark soft tissue, such as breast tissue, for future medical procedures, including radiation therapy. The device has a permanent titanium component and a resorbable plastic component designed to dissolve over time​ (Medical Device Developments)​​ (Health Imaging)​.

Potential Harm from BioZorb and Affected Population

Given the number of BioZorb units sold, the potential impact is significant. The BioZorb recall affects a wide range of healthcare professionals, including radiologists, surgeons, and oncologists, who use these markers in breast cancer procedures. Patients with implanted BioZorb markers are at risk, and those undergoing systemic cancer treatments may experience delays due to complications from the marker.

Lack of Warnings Concerning BioZorb

Many patients with the implanted BioZorb Markers are not aware that they are at risk or know the possible side effects to expect. The device lacks important warnings that consumers and their healthcare professionals should be aware of before the implanting the device.

Biozorb Risk Mitigation and Recommendations

Hologic has issued safety notifications to all affected BioZorb customers, urging patients to contact their healthcare providers if they experience any adverse events. Healthcare providers are advised to continue monitoring patients with the implanted device and report any complications to Hologic and the FDA’s MedWatch Adverse Event Reporting program​ (FDA Access Data)​​ (Medical Device Network)​.

Now, as of October 2024, FDA says not to use BioZorb. 

In summary, the recall of the BioZorb Marker highlights the need for vigilant monitoring and reporting of medical device complications to ensure patient safety and mitigate potential harm.

Stay Informed about BioZORB

KBA continues informing BioZorb patients about the latest developments. Here are some recent blog posts:

FDA Issues Urgent Recall of BioZorb Markers

Understanding the Legal Process in a Personal Injury Case: BioZORB Complications

The Dangers of BioZorb – Dealing with a BioZorb Device Complications and Removal

BioZORB Litigation Ruling: A Turning Point in Medical Device Safety

Understanding BioZORB: Benefits, Complications, and Concerns

BioZORB Medical Device Problems/Lack of Warnings

BioZORB Marker for Breasts Cancer Patients

BioZORB Litigation Ruling: A Turning Point in Medical Device Safety

The Dangers of BioZorb – Dealing with a BioZorb Device Complications and Removal

CONTACT KBA TODAY – What Can KBA Do For You?

We litigate medical device cases at our law firm. We support to individuals who have suffered injuries. Our skilled attorneys are committed to helping you navigate the complexities of personal injury law and claims related to BioZorb. If you or a loved one has suffered harm from this medical device BioZORB – contact us immediately, strict deadlines apply.